期刊文献+

超声诊断甲状腺淋巴瘤1例

Lyinphoma of the thyroid chicguwsed by ultrasound:one case report
下载PDF
导出
摘要 患者男,75岁。“查体发现甲状腺结节1月余”入院,无相关临床症状,查体:颈软,气管居中,双侧甲状腺均可触及大小不一实性结节,质硬,边界不清,随吞咽上下活动。左侧颈部可触及明显肿大淋巴结,双侧下颌及锁骨上未触及明显肿大淋巴结。入院后行超声所见:甲状腺形态不对称,左叶体积明显增大,左叶内探及一较大低回声包块,占据左叶全叶,被膜显示欠清(图1),右叶实质内探及两处低回声结节(图2),上述结节边界清晰,内部回声不均,可见条索样强回声,CDFI:包块内血流信号不丰富。左侧颈部Ⅱ-Ⅵ区探及多个淋巴结回声,形态饱满,边界欠清,回声低弱,皮髓质分界不清,CDFI:内血流信号不丰富。
作者 沙启梅 李霞 刘慧 SHA Qimei;LI Xia;LIU Hui
出处 《医学影像学杂志》 2020年第8期1451-1451,1456,共2页 Journal of Medical Imaging
  • 相关文献

参考文献2

二级参考文献23

  • 1汪清铭,吴祥元.弥漫大B细胞淋巴瘤的分子异质性[J].国外医学(内科学分册),2005,32(8):353-356. 被引量:1
  • 2吴宏菊,张清媛,陈德发,关小军,张伯龙,马军.美罗华联合CHOP方案与CHOP方案治疗初治弥漫性大B细胞淋巴瘤的临床对比研究[J].癌症,2005,24(12):1498-1502. 被引量:33
  • 3陆锦标,李小秋,张培红,周晓燕,张太明,李小妹,朱雄增.结内外弥漫性大B细胞淋巴瘤的免疫表型和分化特征及预后的比较[J].中华病理学杂志,2007,36(7):470-473. 被引量:10
  • 4Pfreundschuh M, Kuhnt E, Trumper L, et al. CHOP-likechemotherapy with or without rituximab in young patients with good- prognosis diffuse large-B-cell lymphoma: 6-year results of an open- label randomised study of the MabThera International Trial (MINT) Group[J]. Lancet Oncol, 2011, 12(11): 1013-1022.
  • 5Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MINT) Group[J]. Lancet Oncol, 2006, 7(5): 379-391.
  • 6Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin Oncol, 2014, 32(27): 305%3068.
  • 7Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP[J]. Blood, 2007, 109(5): 1857-1861.
  • 8Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced international prognostic index(NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era[J]. Blood, 2014, 123(6): 837- 842.
  • 9Aukema SM, Siebert R, Schuuring E, et al. Double-hit B-cell lymphomas[J]. Blood, 2011, 117(8): 2319-2331.
  • 10Barrans S, Crouch S, Smith A, et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab [J]. J Clin Oncol, 2010, 28(20): 3360-3365.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部